Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology.
Amiodarone has become an important drug for the treatment of supraventricular and ventricular arrhythmias, in short-term inpatient and outpatient settings. It may also have a role in affecting outcome in patients at high risk for arrhythmic events and sudden death; its place among available therapies is being established in clinical trials.
Goldschlager
N
N
Cardiology Division, University of California, San Francisco, San Francisco General Hospital, 94110, USA.
Epstein
A E
AE
Naccarelli
G
G
Olshansky
B
B
Singh
B
B
D000284:Administration, Oral; D000638:Amiodarone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D004347:Drug Interactions; D006801:Humans; D007262:Infusions, Intravenous; D016032:Randomized Controlled Trials as Topic
D000889:Anti-Arrhythmia Agents; D000638:Amiodarone